对于妇科恶性瘤的骨盆排泄后的并发症和复发:来自COREPEX研究的生存分析

Nicolò Bizzarri¹, Denis Querleu, Giulio Ricotta+37

• ¹UOC Ginecologia Oncologica, Dipartimento di Scienze Della Salute Della Donna, Del Bambino e di Sanità Pubblica, and the Biostatistics Unit, Scientific Directorate, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, the Unit of Gynecologic Oncology, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples, and the Department of Medicine, University of Udine, and the Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy; the Department of Surgical Oncology, Department of Surgical Oncology and INSERM CRCT Team 19, Oncogenesis of Sarcomas, and the Department of Surgical Oncology and INSERM CRCT Team 1, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France; the First Obstetrics and Gynecology Clinic, "G. E. Palade" University of Medicine, Pharmacy, Science and Technology, Targu Mures, Romania; the Department of Gynecologic Oncology, La Fe University and Polytechnic Hospital, the POG Department University of Valencia, and the CEU Cardenal Herrera University, Valencia, Gynecologic Oncology, Universidad de Navarra, Pamplona, and the Gynecologic Oncology Unit, La Paz University Hospital, Madrid, Spain; the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Başkent University Hospital, Ankara, and the Department of Obstetrics and Gynecology, Koc University School of Medicine and VKV American Hospital, and the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey; the Department of Gynaecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic; the Department of Gynaecology, National Institute of Oncology, Budapest, Hungary; the Department of Pelvic Cancer and Women's and Children's Health, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden; the Department of Gynecology with Center for Oncological Surgery, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Virchow Campus Clinic, Charité Medical University, Berlin, and the Department of Gynecology and Obstetrics, Florence-Nightingale-Hospital, Düsseldorf, Germany; the Northern Gynaecological Oncology Centre (NGOC), Queen Elizabeth Hospital, Gateshead, United Kingdom; the National Cancer Institute, Kiev, Ukraine; the NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus; the Department of Gastrointestinal Surgery, University Hospital Ghent, and Human Structure and Repair, Ghent University, Ghent, Belgium; and the National Cancer Institute, Bratislava, Slovakia.